LISINOPRIL AND HYDROCHLOROTHIAZIDE by Teva is clinical pharmacology lisinopril and hydrochlorothiazide as a result of its diuretic effects, hydrochlorothiazide increases plasma renin activity, increases aldosterone secretion, and decreases serum potassium. Approved for hypertension, to lower blood pressure. First approved in 2002.
Drug data last refreshed 9h ago
CLINICAL PHARMACOLOGY Lisinopril and Hydrochlorothiazide As a result of its diuretic effects, hydrochlorothiazide increases plasma renin activity, increases aldosterone secretion, and decreases serum potassium. Administration of lisinopril blocks the renin-angiotensin aldosterone axis and tends to…
Worked on LISINOPRIL AND HYDROCHLOROTHIAZIDE at Teva? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.